Atrial natriuretic peptide induces postprandial lipid oxidation in humans
- PMID: 18835931
- PMCID: PMC2584124
- DOI: 10.2337/db08-0649
Atrial natriuretic peptide induces postprandial lipid oxidation in humans
Abstract
Objective: Atrial natriuretic peptide (ANP) regulates arterial blood pressure. In addition, ANP has recently been shown to promote human adipose tissue lipolysis through cGMP-mediated hormone-sensitive lipase activation. We hypothesized that ANP increases postprandial free fatty acid (FFA) availability and energy expenditure while decreasing arterial blood pressure.
Research design and methods: We infused human ANP (25 ng . kg(-1) . min(-1)) in 12 men (age 32 +/- 0.8 years, BMI 23.3 +/- 0.4 kg/m(2)) before, during, and 2 h after ingestion of a standardized high-fat test meal in a randomized, double-blind, cross-over fashion. Cardiovascular changes were monitored by continuous electrocardiogram and beat-by-beat blood pressure recordings. Metabolism was monitored through venous blood sampling, intramuscular and subcutaneous abdominal adipose tissue microdialysis, and indirect calorimetry.
Results: ANP infusion decreased mean arterial blood pressure by 4 mmHg during the postprandial phase (P < 0.01 vs. placebo). At the same time, ANP induced lipolysis systemically (P < 0.05 vs. placebo) and locally in subcutaneous abdominal adipose tissue (P < 0.0001 vs. placebo), leading to a 50% increase in venous glycerol (P < 0.01) and FFA (P < 0.05) concentrations compared with placebo. The increase in FFA availability with ANP was paralleled by a 15% increase in lipid oxidation rates (P < 0.05 vs. placebo), driving a substantial increase in postprandial energy expenditure (P < 0.05 vs. placebo).
Conclusions: Our data identify the ANP system as a novel pathway regulating postprandial lipid oxidation, energy expenditure, and concomitantly arterial blood pressure. The findings could have therapeutic implications.
Figures
Similar articles
-
Beta-adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulation.J Clin Endocrinol Metab. 2006 Dec;91(12):5069-75. doi: 10.1210/jc.2006-1084. Epub 2006 Sep 19. J Clin Endocrinol Metab. 2006. PMID: 16984990 Free PMC article.
-
Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans.J Clin Endocrinol Metab. 2005 Jun;90(6):3622-8. doi: 10.1210/jc.2004-1953. Epub 2005 Mar 1. J Clin Endocrinol Metab. 2005. PMID: 15741263
-
Preferential stimulation of abdominal subcutaneous lipolysis after prednisolone exposure in humans.Obes Res. 2002 Aug;10(8):774-81. doi: 10.1038/oby.2002.105. Obes Res. 2002. PMID: 12181386 Clinical Trial.
-
[Natriuretic peptides: a new lipolytic pathway in human fat cells].Med Sci (Paris). 2005 Dec;21 Spec No:29-33. Med Sci (Paris). 2005. PMID: 16598902 Review. French.
-
[Physiological and pathophysiological features of the control of lipolysis and lipid mobilization by natriuretic peptides].J Soc Biol. 2006;200(1):67-76. doi: 10.1051/jbio:2006009. J Soc Biol. 2006. PMID: 17144164 Review. French.
Cited by
-
Effect of sacubitril/valsartan on lipid metabolism in patients with chronic kidney disease combined with chronic heart failure: a retrospective study.Lipids Health Dis. 2024 Feb 28;23(1):63. doi: 10.1186/s12944-024-02051-x. Lipids Health Dis. 2024. PMID: 38419057 Free PMC article.
-
MANP in Hypertension With Metabolic Syndrome: Proof-of-Concept Study of Natriuretic Peptide-Based Therapy for Cardiometabolic Disease.JACC Basic Transl Sci. 2023 Nov 1;9(1):18-29. doi: 10.1016/j.jacbts.2023.08.011. eCollection 2024 Jan. JACC Basic Transl Sci. 2023. PMID: 38362338 Free PMC article.
-
Exercise performance is not improved in mice with skeletal muscle deletion of natriuretic peptide clearance receptor.PLoS One. 2023 Nov 2;18(11):e0293636. doi: 10.1371/journal.pone.0293636. eCollection 2023. PLoS One. 2023. PMID: 37917630 Free PMC article.
-
Cardiac-to-adipose axis in metabolic homeostasis and diseases: special instructions from the heart.Cell Biosci. 2023 Sep 4;13(1):161. doi: 10.1186/s13578-023-01097-1. Cell Biosci. 2023. PMID: 37667400 Free PMC article. Review.
-
Natriuretic Peptide Signaling in Uterine Biology and Preeclampsia.Int J Mol Sci. 2023 Aug 1;24(15):12309. doi: 10.3390/ijms241512309. Int J Mol Sci. 2023. PMID: 37569683 Free PMC article. Review.
References
-
- Hirsch J, Mackintosh RM, Aronne LJ: The effects of drugs used to treat obesity on the autonomic nervous system. Obes Res 8 :227 –233,2000 - PubMed
-
- Halpern A, Mancini MC: Treatment of obesity: an update on anti-obesity medications. Obes Rev 4 :25 –42,2003 - PubMed
-
- Sengenes C, Bouloumie A, Hauner H, Berlan M, Busse R, Lafontan M, Galitzky J: Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes. J Biol Chem 278 :48617 –48626,2003 - PubMed
-
- Sengenes C, Zakaroff-Girard A, Moulin A, Berlan M, Bouloumie A, Lafontan M, Galitzky J: Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity. Am J Physiol Regul Integr Comp Physiol 283 :R257 –R265,2002 - PubMed
-
- Galitzky J, Sengenes C, Thalamas C, Marques MA, Senard JM, Lafontan M, Berlan M: The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men. J Lipid Res 42 :536 –544,2001 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous